Kimia Biosciences Ltd — Updates, 12-06-2025: Company Update

Kimia Biosciences has identified a discrepancy in its previously submitted financials due to omission of quarterly figures for the quarter and financial year ended March 31, 2025, and has submitted revised statements. The company reported revenue from operations of ₹38.24 Cr for the quarter and ₹104.88 Cr for the year. It posted a profit before tax of ₹6.34 Cr for the quarter and ₹13.63 Cr for the year, with earnings per share of ₹0.42 (quarter) and ₹2.03 (year). The balance sheet shows total assets of ₹111.21 Cr and equity of ₹9.97 Cr. Operating cash flow improved significantly to ₹21.31 Cr. The auditor issued a clean report but noted the need for strengthening internal audit and updating asset records. CSR provisions were corrected after reversal of earlier inappropriate accruals. The company’s R&D facility is recognized by DSIR, and related expenses are capitalized per accounting standards, reflecting enhanced compliance.